Orthofix International | OFIX - 销售收入

金融业

USD

USD 850.65M

现金及等价物

USD 82.03M

USD 66.63M

USD 416.85M

USD 170.48M

USD 137.24M

股息收益率

0

USD 6.12M

USD 27.88M

1.09K

EPS每股收益

USD 0.09

股本和储备

USD 450.04M

USD 153.28M

债务利息支出

4.68M

USD 174.45M

USD 435.8M

USD -2.22M

USD 213.79M

USD 6.12M

普通股股本

USD 39.83M

4.17K

USD -2.19M

USD 219.91M

销售和管理费用

USD 130.35M

USD 172.32M

贸易债权人

USD 58.39M

应收帐款人

USD 135.75M

	销售	更改		日
Accuray	USD 116.17M		14.63M	2024-12
AngioDynamics	USD 79.43M		3.72M	2025-09
Artivion	USD 115.99M		2.6M	2025-12
AtriCure	USD 140.5M		6.2M	2025-12
Dexcom	USD 1.26B		50M	2025-12
EDAP TMS	EUR 13.88M		2.16M	2025-09
Globus Medical	USD 826.4M		57.4M	2025-12
Hologic	USD 1.05B		0	2025-12
Inogen	USD 74.93M		504K	2024-09
Insulet	USD 783.8M		77.5M	2025-12
Integra LifeSciences	USD 434.9M		32.84M	2025-12
J&J	USD 24.6B		610M	2025-12
Medtronic	USD 9B		39M	2026-01
Mesa Laboratories	USD 62.84M		5.01M	2024-12
Orthofix International	USD 219.91M		14.28M	2025-12
Plus Therapeutics	USD 1.31M		73K	2023-12
Smith & Nephew	USD 3.18B		353M	2025-12
STAAR Surgical	USD 239.4M		144.7M	2025-12
Stryker	USD 7.2B		1.14B	2025-12
Surmodics	USD 29.92M		96.16M	2024-12
Tandem Diabetes Care	USD 290.4M		41.15M	2025-12
Teleflex	USD 568.98M		344.02M	2025-12
Veracyte	USD 140.6M		8.7M	2025-12
Zimmer Biomet Holdings	USD 2.24B		240M	2025-12